Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focus on investors’ losses and whether they may be recovered under the federal securities laws.

What if I purchased Enochian common stock? If you purchased Enochian common stock and suffered significant losses on your investment, join our investigation now:

There is no cost or obligation to you.

What is Johnson Fistel investigating? On May 25, 2022, the United State Attorney’s Office for the District of Vermont, announced that the co-founder of Enochian Biosciences Inc was arrested Wednesday following a two-year investigation into a man who was kidnapped and found dead in January 2018. Dr. Serhat Gumrukcu, a co-founder of Enochian Biosciences, is being charged with conspiring to use interstate commerce facilities in the commission of murder-for-hire, which resulted in the death of Gregory Davis, a resident of Vermont.

Dr. Gumrukcu sold 253,493 shares of Enochian Biosciences stock on May 18, 2022, for a total value of over $2 million.

Then, on June 1, 2022, market analyst Hindenburg Research published a report regarding Enochian titled “Miracle Cures and Murder For Hire: How A Spoon-Bending Turkish Magician Built A $600 Million Nasdaq-Listed Scam Based On A Lifetime Of Lies[.]” The report noted that the individual in whose murder Gumrukçu was implicated, Gregory Davis, “was murdered … just 19 days before Gumrukcu was scheduled to appear in court to defend himself against felony fraud allegations related to a 2016 deal with Davis” and that “[f]ederal prosecutors argued that the prospective merger deal that eventually resulted in Enochian going public served as a key motive for the murder.” The report also stated that…